NSCLC Biomarkers: Current Landscape and Future Perspectives for Precision Medicine

View an on-demand Webcast of a live CCO Webinar and then download the slides to gain expert perspectives from a medical oncologist and pathologist on biomarker testing and personalized therapy in NSCLC including review of the latest clinical data key strategies for optimal biomarker detection and communication among the multidisciplinary team.

Share

Program Content

Activities

NSCLC Biomarkers: Targeted Therapy
Current and Emerging Biomarkers in Lung Cancer Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 11, 2020

Expires: September 10, 2021

NSCLC Biomarkers: Testing
The Pathologist’s Role in NSCLC Biomarker Testing: Tips for Tissue Triage, Which Markers to Test for, and How
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 11, 2020

Expires: September 10, 2021

EP: NSCLC Biomarkers
ExpressPoints: Current Landscape and Future Perspectives on NSCLC Biomarkers for Precision Medicine
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 11, 2020

Expires: September 10, 2021

Activities

NSCLC Biomarkers
NSCLC Biomarkers: Current Landscape and Future Perspectives for Precision Medicine
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.